Abstract: A process and catalyst are disclosed for the catalytic partial oxidation of light hydrocarbons to produce synthesis gas at superatmospheric pressures. A preferred catalyst used in the process includes a nickel-magnesium oxide solid solution and at least one promoter chosen from Cr, Mn, Mo, W, Sn, Re, Rh, Ru, Ir, Pt, La, Ce, Sm, Yb, Lu, Bi, Sb, In and P, and oxides thereof, carried on a refractory support.

Abstract: A 2-methoxyphenol derivative and an ink composition containing the 2-methoxyphenol derivative, an aqueous medium, and a colorant enhance light resistance by absorbing ultraviolet (UV) light, provide wettability and stabilize a colorant. The ink composition prepared using the 2-methoxyphenol derivative also has improved light resistance, wettability and stabilizes a colorant and does not require an additional light-resistant agent.

Abstract: The invention concerns a method for preparing a thin ceramic material with controlled surface porosity gradient, including (A) infiltrating a porous pore-forming substrate of controlled thickness, with a ceramic material suspension; (B) evaporating the solvent; (C) a step which includes eliminating the pore-forming agents and the various organic additives, and (D) a sintering step. The invention also concerns the use of the ceramic material in the method for preparing a solid electrolyte and a mixed ionic-electronic conductor, in methods for preparing ultra-pure oxygen, for eliminating oxygen from a gaseous atmosphere, for producing heat energy, for preparing gas or liquid filtering membranes, for ceramic/metal joints, for biomaterials and sensors.

Abstract: A method for preparing a composition containing between 0.08 and 3.

Abstract: It is a composite-type mixed oxygen ion and electronic conductor, in which an oxygen ion conductive phase consists of gadolinium-doped cerium oxide (GDC), an electronic conductive phase consists of spinel-type ferrite (CFO), the particle diameters of both phases are 1 ?m or less, respectively, both phases are uniformly mixed mutually, and both phases form respective conductive networks. Both phases have low solid solubility mutually, chemical reactions are not easily caused between both phases, and even if chemical reactions are caused between both phases, different phase to disturb mixed conductivity is not formed. And it has high oxygen permeability, and does not easily cause aged deterioration.

Abstract: A method of producing a polymer-clay nanocomposite comprises providing a supply of polymer-clay mixture, exfoliating the mixture through solid-state shear pulverization in the presence of cooling sufficient to maintain the extruded mixture in the solid state during the pulverization, and discharging the resulting exfoliated mixture. The invention is also directed to a method of producing a polymer hybrid nanocomposite, wherein a component is dispersed throughout a polymer matrix by solid-state shear pulverization of a polymer mixed with the second component.

Abstract: A method of molding a decorative product packaging, comprising the steps of: molding a product container or cap; applying a UV curable liquid to surfaces and/or cavities in the container or cap; then exposing the UV curable liquid to UV radiation to form a solid coating adhered to surfaces and/or filling cavities on the container or cap. The present invention provides dramatic effects, particularly where the container or cap are clear or tinted, because the solid coating can be tinted a contrasting color, providing a striking contrast to the container or cap.

Abstract: Methods and devices for emitting volatile materials are disclosed. In some embodiments, methods and devices for emitting two or more fragrance compositions are disclosed. In one non-limiting embodiment of a device, the device has a housing, and the housing is supported on an electrical outlet by a plug at least indirectly joined to the housing. The device contains a first volatile composition and a second volatile composition. The first volatile composition is emitted in an alternating period relative to said second volatile composition. In one embodiment of the method, the volatile compositions are alternately emitted during periods that are greater than 15 minutes and less than 2 hours.

Abstract: Compositions and methods for emulsifying a petroleum product that has been spilled upon a portion of the earth's surface or that is burning are based upon use of a nonionic, primary surfactant composition comprising a first ethoxylated sorbitol oleate and, preferably, a second ethoxylated sorbitol oleate, and a nonionic, secondary surfactant that is capable of stabilizing and solubilizing the primary surfactant composition such that the resulting emulsifying compositions have a hydrophilic/lipophilic balance between about 12.0 and about 13.5.

Abstract: A method and system for providing a fluidic interface to slides bearing microarrays of biomolecules or other samples immobilized thereon to perform a variety of chemical reactions or processing steps on the slide. An interface device seals against the slide to form a chamber or chambers containing all or a portion of the microarray, providing selective access to portions of the slide. The interface device includes inlet and outlet ports permitting liquid sample and reagents to be introduced to and removed from the chamber accessing the slide surface. Pre- and post-array microfluidic circuitry may be included in the interface device or in attachable modules. The system may include one or more compartments for collecting and storing waste fluids.

Abstract: The present invention provides a detection article including at least one fluid control film layer having at least one microstructured major surface with a plurality of microchannels therein. The microchannels are configured for uninterrupted fluid flow of a fluid sample throughout the article. The film layer includes an acquisition zone for drawing the fluid sample into the plurality of microchannels at least by spontaneous fluid transport. The film layer also includes a detection zone having at least one detection element that facilitates detection of a characteristic of the fluid sample within at least one microchannel of the detection zone.

Abstract: A method and a device are provided for examining the properties of the global, in particular the primary, hemostasis functions in whole blood or platelet-rich plasma. A volumetric blood flow is preferably adjusted, depending on the measured pressure of the volumetric flow, so that the shear rate or the shear force, whose action in the reaction opening causes blood components, in particular thrombocytes, to deposit, follows a predetermined characteristic curve and in particular is held constant.

Abstract: A micro-electro-mechanical system (MEMS) device is described having a membrane which can be induced to resonate and the frequency of its resonance can be monitored. Chemical moieties can be attached to the membrane, and these moieties can be selected such that they have an affinity for molecules of interest, especially biological molecules of interest. When molecules of interest bind to the moieties they increase the mass of the membrane and thereby change the frequency of the membrane's resonance. By monitoring the resonance one can obtain an indication of the presence of the molecules of interest and in some circumstances an indication of the approximate concentration of these molecules. In addition, several types of moieties having affinities for several different molecules of interest can be placed on the membrane in such a way that the sensor can detect the presence of several different types of molecules of interest and distinguish which ones may be present and which ones may be absent.

Abstract: The present invention relates to a chemical sensor arrangement having an analyte sensitive indicator wherein the analyte sensitive indicator has at least one nanoparticle. The invention further relates to a method for providing nanoparticles of defined and different sizes, especially for a chemical sensor arrangement, wherein a nanoparticle solution, having nanoparticles of a broad size distribution, is applied to chromatography beads, whereby the nanoparticles are adsorbed onto said beads and classified by size, and beads of a specific layer, having nanoparticles of essentially the same size, are separated from the beads within other layers and are held in suspension.

Abstract: A biosensor includes a substrate with a layer of receptive material disposed thereon. The receptive material is specific for an analyte of interest. A pattern of active and inactive areas of the receptive material are defined in the receptive material layer by a masking process.

Abstract: An automatic tip changer for an automatic multichannel pipettor comprises a plurality of pipettes arranged in a pipetting head. Each of the pipettes arranged in the pipetting head is directly connected to a tip. A magazine which is outfitted with tips and lying in a magazine frame is pressed against the pipetting head. A supply carousel is provided for storing a plurality of stacking boxes in which magazines outfitted with tips are deposited. A lifting group which is arranged in a stationary manner relative to the supply carousel and the magazines are positioned successively in a mounting plane which is determined by the position of the magazine frame. A sliding group is included which is arranged in a stationary manner relative to the lifting group and by which the magazines are displaceable back and forth successively between the stacking box and the magazine frame.

Abstract: Device for automatically implementing the SPE method, with a two-dimensional needle arrangement which is suitable for removing substances from different two-dimensional specimen vessel arrangements and dispensing them under pressure into a two-dimensional cartridge arrangement.

Abstract: Described herein is microfluidic device for joining fluids and a related method for doing the same. The device according to the present invention includes a microfluidic junction, an outlet channel, and a plurality of circuit units. A microfluidic junction is an area for converging multiple fluids. An outlet channel is capable of receiving fluid from the microfluidic junction. An outlet channel includes a first end connected with the microfluidic junction, a second end connected with a waste reservoir, and an analysis region positioned between the first end and the second end of the outlet channel. The device also includes a plurality of circuit units.

Abstract: A NOx removal system for boilers in which the need for any special heat retainer or any warming mechanism is eliminated. Ammonia jet nozzles are disposed on a gas passage of a boiler or flue, and an ammonia generator connected to the jet nozzles is disposed within the flue.

Abstract: A catalytic reactor comprises a plurality of sheets defining flow channels between then. Within each flow channel is a foil of corrugated material whose surfaces are coated with catalytic material. The flow channels extend in transverse dire options, but the foils are shaped to cause the gas in those channels to flow at least partly in counter current to the gas flowing in the other channels. The reactor incorporates header chambers to supply gas mixtures to the flow channels, each header being in the form of a cap attached to the outside of the back and covering a face of the stack. Hence different gas mixtures are supplied to the different channels which may be at different pressures, and the corresponding chemical reactions are also different, and heat is transferred through the sheets separating the adjacent channels. When the catalyst in one set of flow channels becomes spent, it can be replaced by removing a header.

Abstract: A process for hydroformylating olefinically unsaturated compounds by means of a cobalt-based catalyst is carried out in a non-aqueous ionic liquid which is a liquid at a temperature below 90° C. and comprises at least one ammonium and/or phosphonium and/or sulfonium cation Q+ and at least one anion A?; catalyst recycling is improved by using a ligand selected from the group consisting of Lewis bases and employing a depressurization step between the pressurized reaction step and the step for separating the phases by decanting. At the end of said depressurization step, the organic phase is separated in the decanting step and the non-aqueous ionic liquid containing the catalyst can be re-used.

Abstract: A method and system for controlling one or more emissions includes introducing ammonia to react with at least a portion of sulfur trioxides in an exhaust emission and result in at least one or more ammoniated compounds. At least a portion of fly ash particles and the ammoniated compounds in the exhaust emission are precipitated. At least a portion of the ammonia from the precipitated ammoniated compounds is recovered with heat from the exhaust emission and the recovered ammonia is reused.

Abstract: A method and apparatus for the carbonization of polyacrylonitrile (PAN) precursor fibers. The apparatus comprises a furnace, or series of furnaces in side-by-side arrangement. Each furnace includes a heater, an air inlet and an air diffusion plate. The fiber is located in the furnace above the air diffuser plate, such that heated air is evenly dispersed over the fibers. The method generally comprises the steps of heat treating the PAN precursor in an oxidizing environment to stabilize the fiber, and then further heat treating the stabilized fiber in an oxidizing environment to carbonize the stabilized fiber. The method can be carried out in a single furnace, or can be carried out in a series of furnaces in a continuous process.

Abstract: The present invention is the method for preparation of transition metal oxide having micro-mesoporous structure whose average fine pores size is not less than 1 nm and not more than 2 nm comprising, adding and dissolving transition metal salt which is a precursor of transition metal oxide and/or metal alkoxide in the solution prepared by dissolving polymer surfactant in organic solvent, hydrolyzing said transition metal salt and/or metal alkoxide and preparing sol solution which is polymerized and self organized, then obtaining gel whose organization is stabilized from said sol solution and removing said polymer surfactant by using water of room temperature or water to which alkali metal or alkaline earth metal ion is added.

Abstract: Process for preparing barium titanate or strontium titanate by reacting titanium alkoxides with barium hydroxide hydrate or strontium hydroxide hydrate in a C1–C8-alcohol or a glycol ether at from 50 to 150° C.

Abstract: To provide a process for producing an aluminum oxide powder, whereby the content of impurities is controlled by a physical means. A process for producing an aluminum oxide powder, which comprises pulverizing electrofused alumina by a batch system and classifying the obtained pulverized product to obtain an aluminum oxide powder different in the content of impurities. It is possible to obtain aluminum oxide of high purity by pulverization to a smaller average particle size and separating a powder having a larger average particle size by classification.

Abstract: The invention provides, in a general sense, a new labeling strategy employing 99mTc chelated with ethylenedicysteine (EC). EC is conjugated with a variety of ligands and chelated to 99mTc for use as an imaging agent for tissue-specific diseases. The drug conjugates of the invention may also be used as a prognostic tool or as a tool to deliver therapeutics to specific sites within a mammalian body. Kits for use in tissue-specific disease imaging are also provided.

Abstract: The invention relates to the use of pressurized metered dose inhalers (MDIs) having part or all of their internal surfaces consisting of stainless steel, anodized aluminum or lined with an inert organic coating; and to compositions to be delivered with said MDIs.

Abstract: The present invention relates to a topical composition comprising a malodor-reducing effective amount of a rosemary extract, or active fraction thereof, in combination with a self-tanning effective amount of DHA. The invention also provides a method of reducing the potential for malodor generation of a DHA composition comprising adding to the composition an effective amount of rosemary extract or active fraction thereof.

Abstract: There is provided a composition. The cosmetic composition has the following: one or more particulates; a neutralized, carboxylic acid polymer selected from the group consisting of a carbomer, acrylates/C10-30 alkyl acrylate crosspolymer, and any combination thereof; an amount of a polyoxyethylene/polyoxypropylene block copolymer effective to stabilize and maintain dispersion of the one or more particulates; and about 10 wt % to about 90 wt % water. There is also provided a method for making a sunscreen composition. There is also provided a method of stabilizing and maintaining dispersion of particulates in a cosmetic composition.

Abstract: Cosmetic compositions comprising, in a cosmetically acceptable medium, at least one silicone copolymer with a dynamic viscosity ranging from 1×106 to 100×106 cP and at least one additional silicone. This combination can give cosmetic properties, such as at least one of smoothness, lightness, and softness, without the phenomenon of regressing keratin fibers. These compositions can be used for washing and/or conditioning a keratin material, such as the hair or the skin.

Abstract: A novel cosmetic composition comprising, in a cosmetically acceptable medium, at least one aminosilicone as defined herein having, for example, a contact angle with water ranging from 90° to 180° and at least one conditioner, being able to afford, for example, at least one improved cosmetic property (such as lightness, disentangling, volume and sheen) and/or at least one of long-lasting and remanent effects, as well as uses of the composition, such as for washing and/or conditioning keratin materials such as the hair or the skin.

Abstract: Topical preparations for release of an active agent and to methods of making and using the topical preparations are provided. The preparations may have an internal phase dispersed within an external phase. The internal phase may be a hydrophilic carrier and an active agent. The external phase may be a silicone matrix.

Abstract: A topical composition comprising an antiinflammatory glucocorticoid and a nucleoside analogue antiviral agent in a pharmaceutical carrier characterized in that the carrier comprises about 15 to about 25 weight % propylene glycol and about 10 to about 25 weight percent isopropyl C12–C22 alkanoic ester. The compositions have utility in the treatment or prophylaxis of herpesvirus infections and exhibit superior antiviral and therapeutic efficacy and an improved shelf life.

Abstract: The present invention relates to hyperproliferative diseases. Specifically, the present invention encompasses pharmaceutical compositions comprising a modified Reoviridae virus, wherein the Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance of the composition and reduce the immunogenicity of the composition. Yet further, the invention relates to methods of treating a hyperproliferative disease by administering to a patient an effective amount of the modified Reoviridae virus.

Abstract: The present invention discloses lentogenic viral strains useful in the treatment of cancer. A preferred viral strain of Newcastle Disease Virus (NDV) is specifically characterized in terms of biological activities. The present invention further discloses treatment of cancer by application of a clonal NDV strain to tumors. Another feature of the invention is the use of at least one isolated viral glycoprotein or a subunit or analog thereof or of an isolated polynucleotide encoding the same for the treatment of cancer.

Abstract: Cleavage site for the protease furin is inserted between domains of a membrane glycoprotein. Upon cleavage by furin in the trans-Golgi network, the protein is separated into individual membrane-free domain that retains its native conformation. This protocol can be used to produce virus membrane protein domains for structural analysis and for trials as vaccines.

Abstract: An improved method for treating or preventing a pathological condition in a mammalian subject in which modified mammalian blood is administered to the subject. The method comprises administering to the subject from two to four aliquots of modified mammalian blood, with the administration of any pair of consecutive treatments either being on consecutive days or being separated by a rest period of 1 to 21 days. The treatment is useful for treating or preventing a wide range of pathological conditions in which modified mammalian blood is effective, including preconditioning a mammalian subject to better withstand the adverse effects of ischemic stress, atherosclerosis and rheumatoid arthritis.

Abstract: Monoclonal antibodies which specifically bind human CD23, the low affinity receptor for IgE (FceRII/CD23), and contain either a human gamma-1 or human gamma-3 constant domain, are disclosed. The antibodies are useful for modulating or inhibiting induced IgE expression. Accordingly, they have practical utility in the treatment or prophylaxis of disease conditions wherein inhibition of induced IgE production is therapeutically desirable, including allergic conditions, autoimmune diseases and inflammatory diseases.

Abstract: The present invention is directed to anti-AR antibodies, preferably humanized monoclonal antibodies having the amino acid sequences disclosed herein. The present invention includes a pharmaceutical composition comprising such antibodies. The present invention includes a method of inhibiting cancer cell growth comprising administering such antibodies into a subject. The present invention also provides a method of treating cancer or psoriasis in a subject in need of such a treatment by administering such antibodies to said subject in a pharmaceutically effective amount.

Abstract: Human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor a (hTNF?) are disclosed. These antibodies have high affinity for hTNF? (e.g., Kd=10?8 M or less), a slow off rate for hTNF? dissociation (e.g., Koff=10?3 sec?1 or less) and neutralize hTNF? activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hTNF? and for inhibiting hTNF? activity, e.g., in a human subject suffering from a disorder in which hTNF? activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention.

Abstract: The present invention provides methods and compositions for modulating transendothelial migration (TEM) of leukocytes. In particular, inhibition of TEM can provide a potent therapeutic approach to treating inflammatory conditions. The invention specifically relates to the discovery that CD99 mediates TEM, because blocking CD99 on either endothelial cells or monocytes bloks migration 80-90%. In conjunction with PECAM inhibitors, TEM blockade approaches 100%. CD99 is involved in a step in TEM that is distal to the step controlled by PECAM.

Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-? (TNF?) and are useful in vivo diagnosis and therapy of a number of TNF?-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.

Abstract: The present invention is directed to the use of agents that induce high levels of cell surface molecules to provide targets for immunotoxins directed against the same cell surface molecules. A specific example is given in which all-trans-retinoic acid (RA) is used to induce high levels of CD38 cell surface antigen expression in several myeloid and lymphoid leukemia cells. CD38 was then used as target for delivering plant toxin (gelonin) to leukemia cells. Treatment of leukemia cells with RA induced high levels of CD38 in those cells that otherwise had low CD38 expression. The RA-induced leukemia cells then became exquisitely sensitive to an immunotoxin constructed from an anti-CD38 monoclonal antibody conjugated to the plant toxin gelonin.

Abstract: The invention provides classes of immunomodulatory compositions which comprise an average of one or more immunostimulatory sequence (ISS) containing polynucleotide conjugated, or attached, to antigen. The extent of conjugation affects immunomodulatory properties, such as extent of antigen-specific antibody formation, including Th1-associated antibody formation, and thus these various conjugate classes are useful for modulating the type and extent of immune response. The invention also includes methods of modulating an immune response using these compositions.

Abstract: The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.

Abstract: The present invention relates to pharmaceutical compositions and dietary supplement comprising yeast cells that can produce a healthful benefit in a subject inflicted with stomach cancer. The biological compositions can be used to retard the growth of stomach cancer cells and/or prolonging the time of survival of the subject. The invention also relates to methods for manufacturing the biological compositions.

Abstract: The present invention relates to pharmaceutical compositions and dietary supplement comprising yeast cells that can produce a healthful benefit in a subject inflicted with liver cancer. The biological compositions can be used to retard the growth of liver cancer cells and/or prolonging the time of survival of the subject. The invention also relates to methods for manufacturing the biological compositions.

Abstract: The present invention relates to pharmaceutical compositions and dietary supplement comprising yeast cells that can produce a healthful benefit in a subject inflicted with pancreatic cancer. The biological compositions can be used to retard the growth of pancreatic cancer cells and/or prolonging the time of survival of the subject. The invention also relates to methods for manufacturing the biological compositions.

Abstract: The present invention relates to pharmaceutical compositions and dietary supplement comprising yeast cells that can produce a healthful benefit in a subject inflicted with brain cancer. The biological compositions can be used to retard the growth of brain cancer cells and/or prolonging the time of survival of the subject. The invention also relates to methods for manufacturing the biological compositions.